Literature DB >> 17942642

Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis.

Xianzhong Meng1, Lihua Ao, Yong Song, Ashok Babu, Xiaoping Yang, Maorong Wang, Michael J Weyant, Charles A Dinarello, Joseph C Cleveland, David A Fullerton.   

Abstract

Calcific aortic valve stenosis is the most common indication for surgical valve replacement. Inflammation appears to be one of the mechanisms involved in aortic valve calcification, and valve interstitial cells seem to contribute to that process. Although Toll-like receptors (TLRs) play an important role in the cellular inflammatory response, it is unknown whether human aortic valve interstitial cells (HAVICs) express functional TLRs. We examined the expression of TLR2 and TLR4 in human aortic valve leaflets and in isolated HAVICs and analyzed the response of cultured HAVICs to the TLR2 and TLR4 agonists peptidoglycan (PGN) and LPS. Abundant TLR2 and TLR4 proteins were found in human aortic valve leaflets and in isolated HAVICs, and both receptors were detected in the membrane and cytoplasm of cultured HAVICs. Stimulation by either PGN or LPS resulted in the activation of the NF-kappaB signaling pathway and the production of multiple proinflammatory mediators, including IL-6, IL-8, and ICAM-1. In addition, stimulation by either PGN or LPS upregulated the expression of bone morphogenetic protein-2 (BMP-2) and Runx2, factors associated with osteogenesis. This study demonstrates for the first time that HAVICs express TLR2 and TLR4 and that stimulation of HAVICs by PGN or LPS induces the expression of proinflammatory mediators and the upregulation of osteogenesis-associated factors. These results suggest that TLR2 and TLR4 may play a role in aortic valve inflammation and stenosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942642     DOI: 10.1152/ajpcell.00137.2007

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  67 in total

1.  MicroRNA-214 promotes the calcification of human aortic valve interstitial cells through the acceleration of inflammatory reactions with activated MyD88/NF-κB signaling.

Authors:  Dongdong Zheng; Yue Zang; Haixia Xu; Yan Wang; Xiang Cao; Teng Wang; Min Pan; Jiahai Shi; Xiaofei Li
Journal:  Clin Res Cardiol       Date:  2018-12-05       Impact factor: 5.460

Review 2.  The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.

Authors:  Sammy Elmariah; Emile R Mohler
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

3.  Matrix Gla protein regulates calcification of the aortic valve.

Authors:  Neil Venardos; Daine Bennett; Michael J Weyant; Thomas Brett Reece; Xianzhong Meng; David A Fullerton
Journal:  J Surg Res       Date:  2015-04-25       Impact factor: 2.192

4.  The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-κB signaling, and inflammatory gene expression in human aortic valve cells.

Authors:  Vishal Patel; Katrina Carrion; Andrew Hollands; Andrew Hinton; Thomas Gallegos; Jeffrey Dyo; Roman Sasik; Emma Leire; Gary Hardiman; Salah A Mohamed; Sanjay Nigam; Charles C King; Victor Nizet; Vishal Nigam
Journal:  FASEB J       Date:  2015-01-28       Impact factor: 5.191

5.  Klotho suppresses high phosphate-induced osteogenic responses in human aortic valve interstitial cells through inhibition of Sox9.

Authors:  Fei Li; Qingzhou Yao; Lihua Ao; Joseph C Cleveland; Nianguo Dong; David A Fullerton; Xianzhong Meng
Journal:  J Mol Med (Berl)       Date:  2017-03-22       Impact factor: 4.599

6.  Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2.

Authors:  Habib Derbali; Yohan Bossé; Nancy Côté; Philippe Pibarot; Audrey Audet; Andree Pépin; Benoit Arsenault; Christian Couture; Jean-Pierre Després; Patrick Mathieu
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

Review 7.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

Review 8.  Adaptive immune cells in calcific aortic valve disease.

Authors:  Michael A Raddatz; Meena S Madhur; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-03       Impact factor: 4.733

9.  Reduced sox9 function promotes heart valve calcification phenotypes in vivo.

Authors:  Jacqueline D Peacock; Agata K Levay; Devin B Gillaspie; Ge Tao; Joy Lincoln
Journal:  Circ Res       Date:  2010-01-07       Impact factor: 17.367

10.  Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves.

Authors:  Qingchun Zeng; Chunhua Jin; Lihua Ao; Joseph C Cleveland; Rui Song; Dingli Xu; David A Fullerton; Xianzhong Meng
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.